Cardiovascular Risk Reduction Program for American Indians with Metabolic Syndrome The Balance Study
Product Description:
The Balance Study is a randomized controlled trial designed to reduce cardiovascular disease (CVD) risk in 200 American Indian (AI) participants with metabolic syndrome who reside in southwestern Oklahoma. Major risk factors targeted include weight, diet, and physical activity. Participants are assigned randomly to one of two groups, a guided or a self-managed group. The guided group attends intervention meetings that comprise education and experience with the following components: diet, exercise, AI culture, and attention to emotional wellbeing. The self-managed group receives printed CVD prevention materials that are generally available. The duration of the intervention is 24 months. Several outcome variables will be compared between the two groups to assess the effectiveness of the intervention program.
Keyword(s):
Cardiovascular disease, Risk Reduction, Balance Study, American Indians
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Consumers/Families, Professionals, Policymakers, Students
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A